arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Absci Corp

ABSI
$9.34 ▼ -1.16 (-11.10%) at close
Industrials ·Services-Commercial Physical & Biological Research ·USServices-Commercial Physical & Biological Research
7 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Absci Corp faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.3B
Dividend Yield —
Revenue Growth -38.2% ↘
Op. Margin None
ROIC -63.5% ↘
FCF / Share $-0.69 ↘
Trailing P/E —
Price / Book 6.7x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

7-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$2.80M
↓ -38.2% —
Net Income Profit after all expenses
$-115.18M
↓ -11.7% —
FCF / Share Free cash flow per share
$-0.69
↓ -4.1% —
Long-Term Debt Long-term obligations
$3.99M
↓ -49.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
14
Financial Health ↓
5
Cash Quality ↓
55

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters